Tag: INDIAN PHARMA NEWS
Dabur India Plant Under US FDA Scanner Over Contamination Concerns
The United States Food and Drug Administration (US FDA) has flagged serious concerns at Dabur India's manufacturing facility in Silvassa, Dadra and Nagar Haveli,...
FDA Approves Wockhardt’s Novel Antibiotic ZAYNICH™️ for cUTI
Wockhardt Limited announced that the U.S. Food and Drug Administration (FDA) has approved ZAYNICH™ (cefepimeand zidebactam), a novel intravenous antibiotic for treating adults with complicated urinary...
Relief for Patients: NPPA Fixes Ceiling Prices for 30 Essential Medicines
The National Pharmaceutical Pricing Authority (NPPA) has notified ceiling prices for 30 essential fixed-dose combination medicines under the Drugs (Prices Control) Order, 2013, with...
MSPC Launches ₹5 Lakh Support Scheme for Maharashtra Pharmacists
The Maharashtra State Pharmacy Council (MSPC) has introduced the Pharmacist Suraksha Kavach Yojna, a welfare scheme offering ₹5 lakh financial support to the family of...
West Bengal’s CM Suvendu Adhikari Launches Free Statewide Cervical Cancer Shield for 7.5 Lakh Girls
In a major boost to women's healthcare in the state, West Bengal Chief Minister Suvendu Adhikari on Saturday officially launched a massive, statewide Human Papillomavirus (HPV) vaccination campaign. The...
AbbVie’s DECNUPAZ™ got Approval from FDA: First and Only Antibody-Drug Conjugate (ADC) Treatment
AbbVie (NYSE: ABBV) announced that the U.S. Food and Drug Administration (FDA) has approved DECNUPAZTM (pivekimab sunirine-pvzy), first and only antibody-drug conjugate (ADC) drug for the treatment of Blastic Plasmacytoid Dendritic Cell...